Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
Clin Mol Hepatol. 2016;22(3):327-335.   Published online 2016 Sep 25     DOI: https://doi.org/10.3350/cmh.2016.0049
Citations to this article as recorded by Crossref logo
Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee
Medicine.2019; 98(6): e14139.     CrossRef
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
In Cheol Yoon, Jong Ryeol Eun
Yeungnam University Journal of Medicine.2019; 36(2): 67.     CrossRef
The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease
Young-Kyu Kim, Oh-Sung Kwon, Kyu Hee Her
Medicine.2019; 98(27): e16018.     CrossRef
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010–2015
Yunkoo Kang, Sowon Park, Seung Kim, Hong Koh
BMC Pediatrics.2018;[Epub]     CrossRef
Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji
Hepatitis Monthly.2018;[Epub]     CrossRef
CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model
Myong-Min Lee, Hyeong-Geug Kim, Sung-Bae Lee, Jin-Seok Lee, Won-Yong Kim, Seung-Hoon Choi, Sam-Keun Lee, Chang-Kyu Byun, Pung-Mi Hyun, Chang-Gue Son
Phytomedicine.2018; 41: 24.     CrossRef
Neue und bewährte Therapieansätze bei NASH
Peter C. Konturek
MMW - Fortschritte der Medizin.2018; 160(5): 50.     CrossRef
Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea
Yunkoo Kang, Sowon Park, Seung Kim, Hong Koh
Journal of Korean Medical Science.2018;[Epub]     CrossRef
Recent advances in understanding and managing non-alcoholic fatty liver disease
Somaya Albhaisi, Arun Sanyal
F1000Research.2018; 7: 720.     CrossRef
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison, Manal F. Abdelmalek, Stephen Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric J. Lawitz, Don C. Rockey, Raul Aguilar Schall, Catherine Jia, Bryan J. McColgan, John G. McHutchison, G. Mani Subramanian, Robert P. Myers,
Gastroenterology.2018; 155(4): 1140.     CrossRef
Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer
Guozhen Cui, Robert C Martin, Xingkai Liu, Qianqian Zheng, Harshul Pandit, Ping Zhang, Wei Li, Yan Li
Nutrition & Metabolism.2018;[Epub]     CrossRef
Serotonin signals through a gut-liver axis to regulate hepatic steatosis
Wonsuk Choi, Jun Namkung, Inseon Hwang, Hyeongseok Kim, Ajin Lim, Hye Jung Park, Hye Won Lee, Kwang-Hyub Han, Seongyeol Park, Ji-Seon Jeong, Geul Bang, Young Hwan Kim, Vijay K. Yadav, Gerard Karsenty, Young Seok Ju, Chan Choi, Jae Myoung Suh, Jun Yong Par
Nature Communications.2018;[Epub]     CrossRef
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Waqar Khalid Saeed, Dae Won Jun, Kiseok Jang, Sang Bong Ahn, Ju Hee Oh, Yeon Ji Chae, Jai Sun Lee, Hyeon Tae Kang
World Journal of Gastroenterology.2018; 24(48): 5477.     CrossRef
Changes in the Structure of the Liver during Obesity (Literature Review)
V. I. Prymachenko
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2018; 4(2): 45.     CrossRef
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, Francesco Baratta, Paola Coletta, Michele Di Martino, Lorenzo Loffredo, Ludovica Perri, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Carlo Catalano, Marianna Maranghi
Atherosclerosis.2017; 257: 232.     CrossRef
Salvia-Nelumbinis Naturalis Formula Improved Inflammation in LPS Stressed Macrophages via Upregulating MicroRNA-152
Zansong Ma, Xiangbing Shu, Jie Huang, Haiyan Zhang, Zhen Xiao, Li Zhang
Mediators of Inflammation.2017; 2017: 1.     CrossRef
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos
Metabolism.2017; 71: 182.     CrossRef
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han
Digestive Diseases and Sciences.2017; 62(8): 2150.     CrossRef
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran
Journal of Clinical and Translational Hepatology.2017; XX(XX): XX.     CrossRef
A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
Baek Gyu Jun, Won Young Park, Eui Ju Park, Jae Young Jang, Soung Won Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So Young Jin, Suyeon Park, Seung Up Kim
PLOS ONE.2017; 12(8): e0182784.     CrossRef
The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
Hye Won Lee, Kwang Joon Kim, Kyu Sik Jung, Young Eun Chon, Ji Hye Huh, Kyeong Hye Park, Jae Bock Chung, Chang Oh Kim, Kwang-Hyub Han, Jun Yong Park, Han-Chieh Lin
PLOS ONE.2017; 12(10): e0187066.     CrossRef